Neonatal NLRP3 Inflammasome Activation Leads to Perineuronal Net Deficits in Early Adulthood
Developmental Neurobiology · 2025-07 · 85 (3)
DOI: 10.1002/dneu.22986 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Neurobiology, online erschienen am 19.06.2025. Verfasst von Emre Tarakcioglu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Izmir Biomedicine and Genome Center, Izmir, Turkey. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes, Extracellular Matrix, Neurons. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (TÜBİTAK).
Abstract (Originalsprache)
Perineuronal nets (PNNs) are specialized extracellular matrix structures that surround certain neurons and play a critical role in protecting neurons from oxidative stress and maintaining synaptic stability in the central nervous system. They have roles in memory formation, and their loss has been linked to various mental alterations, such as anxiety, depression, and schizophrenia. While immune activation is known to degrade PNNs, it remains unclear whether inflammasomes are involved in PNN formation dynamics during neuronal development, where cases of sepsis are particularly high. In this study, we investigated how activation of the NLRP3 inflammasome in neonatal mouse brains influences PNNs. To explore this, neonatal wild‐type and Nlrp3 knockout mice were injected with lipopolysaccharide (LPS) or phosphate‐buffered saline (PBS) on postnatal day (PND) 9, and PNNs were visualized at early adulthood (PND60). In addition, NLRP3 inflammasome activation was confirmed on PND10, and behavioral tests were performed on PND60. LPS treatment in wild‐type mice reduced PNN‐positive neurons in the hippocampus and cortex compared to the PBS group, whereas Nlrp3 knockout mice showed no differences between treatment groups. Moreover, behavioral tests revealed that neonatal LPS injection resulted in anxiety‐ and depressive‐like behavior and that NLRP3 deficiency restrained this effect. These results highlight the key role of NLRP3 inflammasome activation in inflammation‐driven PNN reduction during neuronal development. NLRP3 inhibitors could thus serve as potential therapeutic agents to protect the neuronal extracellular matrix from inflammatory damage in early life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Izmir Biomedicine and Genome Center, Izmir, Turkey.
- Izmir International Biomedicine and Genome Institute, Dokuz Eylul University, Izmir, Turkey.
- Center for Brain and Neuroscience Research, Izmir Democracy University, Izmir, Turkey.
- Department of Health Care Services, Vocational School of Health Services, Izmir Democracy University, Izmir, Turkey.
- Department of Neuroscience, Health Sciences Institute, Dokuz Eylul University, Izmir, Turkey.
Förderung
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (TÜBİTAK)
Zitieren
APA
Tarakcioglu, E., Genc, B., Tufekci, K. U., & Genc, S. (2025). Neonatal NLRP3 Inflammasome Activation Leads to Perineuronal Net Deficits in Early Adulthood. Developmental Neurobiology, 85(3). https://doi.org/10.1002/dneu.22986
Vancouver
Tarakcioglu E, Genc B, Tufekci KU, Genc S. Neonatal NLRP3 Inflammasome Activation Leads to Perineuronal Net Deficits in Early Adulthood. Developmental Neurobiology. 2025;85(3). doi:10.1002/dneu.22986
BibTeX
@article{Tarakcioglu2025,
author = {Tarakcioglu, Emre and Genc, Bilgesu and Tufekci, Kemal Ugur and Genc, Sermin},
title = {Neonatal NLRP3 Inflammasome Activation Leads to Perineuronal Net Deficits in Early Adulthood},
journal = {Developmental Neurobiology},
year = {2025},
volume = {85},
number = {3},
doi = {10.1002/dneu.22986}
}
EUVIMED